Tekmira (TKMR) Approached by Sierra Leon About Getting Access to Its Drug

Developers of unproven treatments or vaccines for the deadly Ebola virus that include Tekmira Pharmaceuticals Corp. (TKMR), BioCryst Pharmaceuticals Inc. (BCRX), and Sarepta Therapeutics (SRPT) have received backing from the World Health Organization [WHO] to offer interventions as potential treatment or prevention for the Ebola virus which has killed more than 1,000 people in four […] View the full post at: Tekmira (TKMR) Approached by Sierra Leon About Getting Access to Its Drug Related posts: American Innovation in Health Care is Alive and Well Warner Chilcott to Announce a $3B Acquisition of Procter & Gamble’s Drug Unit